赫力昂
✦ 量化合理价值 计算方式说明
- 基于该股自身过去5年平均市盈率乘以滚动每股收益,推算出的合理价值区间为9.71-14.35。
- 当前价格比按平均倍数计算的合理价值(12.03)低15.8%。
估值 各估值倍数与自身5年区间的对比
同业对比 Drug Manufacturers - Specialty & Generic
| 公司 | 市值 | 市盈率(TTM)i | 市净率i | 股息率i |
|---|---|---|---|---|
| 赫力昂 (HLN) | 44.55B | 21.06 | 2.05 | 1.88% |
| Takeda Pharmaceutical (TAK) | 62.84B | -59.43 | 1.31 | 3.04% |
| Teva Pharmaceutical Industries (TEVA) | 48.40B | 69.17 | 6.24 | 0.00% |
| Zoetis (ZTS) | 32.80B | 12.95 | 10.42 | 2.60% |
| United Therapeutics (UTHR) | 22.87B | 19.10 | 3.57 | 0.00% |
| Viatris (VTRS) | 21.43B | -50.42 | 1.50 | 2.57% |
StockVane 追踪范围内同行业的其他公司。
Morningstar
当前股价低于晨星合理价值估算2.5%。
合理价值
Haleon PLC earns a 5-star quantitative star rating, illustrating our stance that this share class offers a compelling opportunity for investors. The stock currently trades at a 10% discount to our quantitative fair value estimate of $10.38 per share, which is reinforced by this estimate's low uncertainty rating.
The firm's profitability bolsters our fair value estimate. Highly profitable companies are often more resilient in recessions and are likely to generate stronger future cash flows for shareholders. For example, the firm's earnings yield of 6.1% lies in the top 40% compared with global peers. This suggests that it is generating substantial earnings relative to its share price, which contributes to our view that shares are cheap.
Conversely, the firm's balance sheet is potentially concerning. Excessive leverage heightens financial risk, potentially undermining a firm's value. The firm's EBITDA/interest coverage ratio of 8.5, a core component of leverage, sits in the bottom 40% globally. This gives us pause, as it can be a warning sign of financial distress if conditions don't improve. Despite our favorable price/fair value ratio, this characteristic is a negative attribute.
经济护城河
The company's excess returns on capital and superb profitability, which could persist for decades or more, warrant a wide economic moat rating. This is supported by the company's strong financial health score, which indicates a low likelihood that the company will tumble into financial distress.
作者:Quantitative Equity Report
报价时间 2026-10-16 20:02:17 · 仅供参考,不构成投资建议,也未考虑您的具体情况。
赫力昂 讨论区 0 条评论